Molecular formula: | C24H28N8O2 |
Average mass: | 460.542 |
Monoisotopic mass: | 460.233522 |
ChemSpider ID: | 29315044 |
1282512-48-4
[RN]1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
[ACD/Index Name]2-{4-[2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamid
[German]
[ACD/IUPAC Name]2-{4-[2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]-1H-pyrazol-1-yl}-2-methylpropanamide
[ACD/IUPAC Name]2-{4-[2-(1-Isopropyl-3-méthyl-1H-1,2,4-triazol-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazépin-9-yl]-1H-pyrazol-1-yl}-2-méthylpropanamide
[French]
[ACD/IUPAC Name]L08J2O299M
[UNII]Taselisib
[USAN] [INN]Taselisib
[Spanish]
[INN]Tasélisib
[French]
[INN]Taselisibum
[Latin]
[INN]2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide
2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide(GDC-0032)
2-Methyl-2-(4-{2-[3-Methyl-1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-5,6-Dihydroimidazo[1,2-D][1,4]benzoxazepin-9-Yl}-1h-Pyrazol-1-Yl)propanamide
4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide
95%
CC(C)N1N=C(C)N=C1C1=CN2CCOC3=C(C=CC(=C3)C3=CN(N=C3)C(C)(C)C(N)=O)C2=N1
MFCD26142641
[MDL number]MFCD28167893
[MDL number]P85A_HUMAN
P85B_HUMAN
PK3CA_HUMAN
PK3CB_HUMAN
PK3CD_HUMAN
PK3CG_HUMAN
tasélisib
Taselisib (GDC 0032)
Taselisib (GDC0032)
Taselisib;RG-7604;GDC0032;GDC 0032
taselisibum
таселисиб
[Russian]تاسيليسيب
[Arabic]他司利塞
[Chinese]